Via Transportation, Inc. (VIA) Spending and interest coverage
- R&D / revenue · 12 months: Value 20.11%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 10.69%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 20.11% | Research and development expense / revenue. Period ending 2026-06-30. $98.91M ÷ $491.70M × 100 ≈ 20.11% |
| Stock-based compensation / revenue · 12 months | 10.69% | Share-based compensation / revenue. Period ending 2026-06-30. $52.56M ÷ $491.70M × 100 ≈ 10.69% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 98.91M USD | Research and Development Expense |
| Revenue | 491.70M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 52.56M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -88.62M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $98.91M | $491.70M | $52.56M | $-88.62M | (m) | 20.11% | 10.69% | (m) | (m) |
| 2026-03-31 | $95.53M | $463.13M | $41.21M | $-82.98M | (m) | 20.63% | 8.90% | (m) | (m) |
| 2025-12-31 | $92.35M | $434.34M | $30.34M | $-76.62M | (m) | 21.26% | 6.99% | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $88.99M | $337.63M | $21.23M | $-83.90M | (m) | 26.36% | 6.29% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $95.83M | $248.85M | $13.13M | $-114.45M | (m) | 38.51% | 5.27% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.